Results 211 to 220 of about 68,962 (266)

Hyperglycemia induces an immunosuppressive microenvironment in colorectal cancer liver metastases by recruiting peripheral blood monocytes through the CCL3-CCR1 axis. [PDF]

J Immunother Cancer
Peng H, Pan Y, Sun Y, Wang X, Fan X, Wang Y, Zhao L, Li X, Dong Y, Chen J, Zhou J, Du Y, Yu Q, Yang Y, Zhang Y, Li J, Liang H, Huang S.   +17 more
europepmc   +1 more source

Planned Liver Stereotactic Body Radiotherapy for Residual Colorectal Cancer Liver Metastases After Surgery: A Single-Arm Retrospective Study. [PDF]

Curr Oncol
Li S, Dong D, Zheng X, Wang H, Wang K, Xing B, Wang W.   +6 more
europepmc   +1 more source

Differential prognostic impact of liver resection by the site of concurrent extrahepatic diseases in patients with colorectal cancer liver metastases: a nationwide multicenter study. [PDF]

Int J Surg
Kato H, Seishima R, Okui J, Shigeta K, Sato Y, Kobayashi S, Sakamoto K, Kobayashi H, Kawai K, Tani K, Ajioka Y, Endo I, Takahashi K, Okabayashi K, Kitagawa Y, Joint Committee of Liver Metastases Survey from Colorectal Cancer.   +15 more
europepmc   +1 more source

Parenchymal-sparing non-anatomic resection vs. classic anatomic resection in colorectal cancer liver metastases. [PDF]

Ann Hepatobiliary Pancreat Surg
Jung S.
europepmc   +1 more source

Integrating Biomarker‐Based Fatty Liver Indices Into Multidisciplinary Treatment Pathways for Digestive Tumors

iLABMED, EarlyView.
Xudong Song, Jingjing Dai, Guoquan Tao
wiley   +1 more source

From Development to Implementation: A Systematic Review on the Current Maturity Status of Artificial Intelligence Models for Patients with Colorectal Cancer Liver Metastases.

Oncology
Kemna R, Zeeuw JM, Ziesemer KA, Ali M, Bereska JI, Marquering H, Stoker J, Verpalen IM, Swijnenburg RJ, Huiskens J, Kazemier G.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Transplant for colorectal cancer liver metastases

Surgery, 2023
Colorectal cancer with unresectable liver metastases has significant mortality when treated with chemotherapy alone. In appropriately selected patients, liver transplant is emerging as a treatment alternative for this population. Some key clinical trials, including SECA-I and SECA-II, have shown promising survival results: more trials are being ...
Jenna N. Whitrock, Stephen J. Hartman, Shimul A. Shah   +2 more
openaire   +2 more sources

Liver Metastases in Colorectal Cancer

American Society of Clinical Oncology Educational Book, 2016
Resection of colorectal liver metastases is a treatment standard because patients experience long-term disease-free survival or are even cured after undergoing this procedure. Improved surgical techniques for liver resection in combination with downsizing liver metastases by chemotherapy, interventions to induce liver hypertrophy before resection, and
openaire   +2 more sources

Surgical Management of Colorectal Cancer Liver Metastases

Hematology/Oncology Clinics of North America, 2021
Approximately 50% of colorectal cancer patients develop liver metastases. Hepatic metastases represent the most common cause of colorectal cancer-related mortality. Metastasectomy, if possible, represents the most effective treatment strategy; 20% of patients will be cured and more than 50% survive at least 5 years.
Chandrasekhar, Padmanabhan, Daniel P, Nussbaum, Michael, D'Angelica   +2 more
openaire   +3 more sources

Liver Resection for Colorectal Cancer: Liver Metastases in the Aged

The American Surgeon, 2000
The purpose of this study was to determine the morbidity and mortality in elderly patients undergoing liver resections for metastatic colon cancer and compare them with those of a control group of younger patients. The charts of all patients undergoing liver resection for colon cancer were retrospectively reviewed.
M I, Brand, T J, Saclarides, H D, Dobson, K W, Millikan   +3 more
openaire   +2 more sources